Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C JARVIS

Showing results (321-330 of 465) with videos related to

Pageof 47
Sort By:
Molecular Genetics and Metabolism|July 30, 2018
Nitisinone arrests ochronosis and decreases rate of progression of Alkaptonuria: Evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria CentreL R Ranganath, M Khedr, A M Milan, et al.
Data in Brief|September 29, 2018
Data on items of AKUSSI in Alkaptonuria collected over three years from the United Kingdom National Alkaptonuria Centre and the impact of nitisinoneR Griffin, E E Psarelli, T F Cox, et al.
Journal of Inherited Metabolic Disease|October 15, 2019
Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuriaLakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, et al.
Annals of the Rheumatic Diseases|December 6, 2014
Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatmentLakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, et al.
The Lancet. Diabetes & Endocrinology|August 22, 2020
Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trialLakshminarayan R Ranganath, Eftychia Eirini Psarelli, Jean-Baptiste Arnoux, et al.
Journal of Microscopy|July 2, 2021
QUAREP-LiMi: A community-driven initiative to establish guidelines for quality assessment and reproducibility for instruments and images in light microscopyGlyn Nelson, Ulrike Boehm, Steve Bagley, et al.
Physical Review Letters|October 2, 2009
Observation of single top-quark productionV M Abazov, B Abbott, M Abolins, et al.
Physical Review Letters|August 8, 2009
Search for the standard model Higgs boson in tau final statesV M Abazov, B Abbott, M Abolins, et al.
Physical Review Letters|June 13, 2009
Measurement of the Zgamma --> nunu[over ]gamma production cross section and limits on anomalous ZZgamma and Zgammagamma couplings in pp[over] collisions at sqrt[s] = 1.96 TeVV M Abazov, B Abbott, M Abolins, et al.
Physical Review Letters|April 7, 2010
Measurement of the WW production cross section with dilepton final states in pp collisions at square root(s) = 1.96 TeV and limits on anomalous trilinear gauge couplingsV M Abazov, B Abbott, M Abolins, et al.
Pageof 47

Showing results (321-330 of 465) with videos related to

Sort By:
Pageof 47
Molecular Genetics and Metabolism|July 30, 2018
Nitisinone arrests ochronosis and decreases rate of progression of Alkaptonuria: Evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria CentreL R Ranganath, M Khedr, A M Milan, et al.
Data in Brief|September 29, 2018
Data on items of AKUSSI in Alkaptonuria collected over three years from the United Kingdom National Alkaptonuria Centre and the impact of nitisinoneR Griffin, E E Psarelli, T F Cox, et al.
Journal of Inherited Metabolic Disease|October 15, 2019
Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuriaLakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, et al.
Annals of the Rheumatic Diseases|December 6, 2014
Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatmentLakshminarayan R Ranganath, Anna M Milan, Andrew T Hughes, et al.
The Lancet. Diabetes & Endocrinology|August 22, 2020
Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trialLakshminarayan R Ranganath, Eftychia Eirini Psarelli, Jean-Baptiste Arnoux, et al.
Journal of Microscopy|July 2, 2021
QUAREP-LiMi: A community-driven initiative to establish guidelines for quality assessment and reproducibility for instruments and images in light microscopyGlyn Nelson, Ulrike Boehm, Steve Bagley, et al.
Physical Review Letters|October 2, 2009
Observation of single top-quark productionV M Abazov, B Abbott, M Abolins, et al.
Physical Review Letters|August 8, 2009
Search for the standard model Higgs boson in tau final statesV M Abazov, B Abbott, M Abolins, et al.
Physical Review Letters|June 13, 2009
Measurement of the Zgamma --> nunu[over ]gamma production cross section and limits on anomalous ZZgamma and Zgammagamma couplings in pp[over] collisions at sqrt[s] = 1.96 TeVV M Abazov, B Abbott, M Abolins, et al.
Physical Review Letters|April 7, 2010
Measurement of the WW production cross section with dilepton final states in pp collisions at square root(s) = 1.96 TeV and limits on anomalous trilinear gauge couplingsV M Abazov, B Abbott, M Abolins, et al.
Pageof 47